The use of salmeterol is prohibited in the study due to its unknown potential for drug-drug interactions with study medication. In addition, there is a warning in the product's information for subjects with liver disease to use this only under doctors care. The Sponsor is not aware of any direct evidence that the consumption of this drug could harm a patient on the current trial and its exclusion was a precautionary measure.